Hematology Analyzers
APAC · 2 shared keywords
Updated
Reviewed by Vidhi Upadhyay
APAC Autoimmune Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Product, Disease, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.04 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.08 Bn | — | — |
| 2025 (base) | $1.16 Bn | +$79.9 Mn | — |
| 2026 (forecast) | $1.25 Bn | +$85.8 Mn | +7.4% |
| 2027 (forecast) | $1.34 Bn | +$92.1 Mn | +15.3% |
| 2028 (forecast) | $1.44 Bn | +$98.9 Mn | +23.9% |
| 2029 (forecast) | $1.54 Bn | +$106.3 Mn | +33.1% |
| 2030 (forecast) | $1.66 Bn | +$114.1 Mn | +42.9% |
| 2031 (forecast) | $1.78 Bn | +$122.6 Mn | +53.5% |
| 2032 (forecast) | $1.91 Bn | +$131.7 Mn | +64.8% |
| 2033 (forecast) | $2.05 Bn | +$141.4 Mn | +77% |
| 2034 (forecast) | $2.20 Bn | +$151.9 Mn | +90.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.16 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.20 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, disease and end user (see all) |
| Key players | Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Werfen, Siemens Healthineers, Euroimmun and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Autoimmune disease diagnostics are blood tests that find antibodies and markers to diagnose and track diseases such as lupus and arthritis.
Key segments of the autoimmune disease diagnostics market include product (Immunoassay Kits, Analyzers and Reagents) and disease (Rheumatoid Arthritis, Lupus and Multiple Sclerosis).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the autoimmune disease diagnostics market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the autoimmune disease diagnostics market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the autoimmune disease diagnostics market.
The autoimmune disease diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by TGA (Australia)[1], NMPA (China)[2], MDACS (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], MDA (Malaysia)[6], Medsafe (WAND) (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9], Thai FDA (Thailand)[10], Ministry of Health (Indonesia)[11], DRAP (Pakistan)[12], MFDS (South Korea)[13] and Ministry of Health (Vietnam)[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)[15], basic medical insurance (China)[16], the Hospital Authority (Hong Kong)[17], Ayushman Bharat PM-JAY (India)[18], public health insurance (Japan)[19], subsidised public care (Malaysia)[20], Pharmac (New Zealand)[21], PhilHealth (Philippines)[22], MediShield Life (Singapore)[23], the Universal Coverage Scheme (Thailand)[24], JKN (BPJS Kesehatan) (Indonesia)[25], out of pocket and Sehat Sahulat (Pakistan)[26], National Health Insurance (South Korea)[27] and social health insurance (Vietnam)[28].
[1] Therapeutic Goods Administration. Checked 14 Nov 2026.
[2] National Medical Products Administration. Checked 14 Nov 2026.
[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.
[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[6] Medical Device Authority. Checked 14 Nov 2026.
[7] Medsafe. Checked 14 Nov 2026.
[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[9] Health Sciences Authority. Checked 14 Nov 2026.
[10] Thai Food and Drug Administration. Checked 14 Nov 2026.
[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.
[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.
[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.
[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.
[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
[16] National Healthcare Security Administration. Checked 14 Nov 2026.
[17] Hospital Authority. Checked 14 Nov 2026.
[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.
[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
[20] Ministry of Health Malaysia. Checked 14 Nov 2026.
[21] Pharmac. Checked 14 Nov 2026.
[22] PhilHealth. Checked 14 Nov 2026.
[23] CPF Board, MediShield Life. Checked 14 Nov 2026.
[24] National Health Security Office. Checked 14 Nov 2026.
[25] BPJS Kesehatan. Checked 19 Nov 2026.
[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.
[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.
[28] Vietnam Social Security. Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how autoimmune disease diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
From our blog
APAC · 2 shared keywords
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
Digital Health · APAC
Healthcare Services · APAC
Healthcare Services · APAC
Pharmaceuticals · APAC
Pharmaceuticals · APAC
Healthcare Services · APAC